These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15125499)

  • 21. Anti-lipase activity of Kampo formulations, coptidis rhizoma and its alkaloids against Propionibacterium acnes.
    Higaki S; Nakamura M; Morohashi M; Hasegawa Y; Yamagishi T
    J Dermatol; 1996 May; 23(5):310-4. PubMed ID: 8675819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotic-resistant Propionibacterium acnes among acne patients in a regional skin centre in Hong Kong.
    Luk NM; Hui M; Lee HC; Fu LH; Liu ZH; Lam LY; Eastel M; Chan YK; Tang LS; Cheng TS; Siu FY; Ng SC; Lai YK; Ho KM
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):31-6. PubMed ID: 22103749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study.
    Dreno B; Foulc P; Reynaud A; Moyse D; Habert H; Richet H
    Eur J Dermatol; 2005; 15(3):152-5. PubMed ID: 15908296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibiotic sensitivity of Propionibacterium acnes isolates from patients with acne vulgaris in a tertiary dermatological referral centre in Singapore.
    Tan HH; Goh CL; Yeo MG; Tan ML
    Ann Acad Med Singap; 2001 Jan; 30(1):22-5. PubMed ID: 11242619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitivity of Propionibacterium acnes isolated from acne patients: comparative study of antimicrobial agents.
    Nishijima S; Kurokawa I; Kawabata S
    J Int Med Res; 1996; 24(6):473-7. PubMed ID: 8959531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of Propionibacterium acnes lipase activity by the antifungal agent ketoconazole.
    Unno M; Cho O; Sugita T
    Microbiol Immunol; 2017 Jan; 61(1):42-44. PubMed ID: 28111792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia.
    Ross JI; Snelling AM; Eady EA; Cove JH; Cunliffe WJ; Leyden JJ; Collignon P; Dréno B; Reynaud A; Fluhr J; Oshima S
    Br J Dermatol; 2001 Feb; 144(2):339-46. PubMed ID: 11251569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Roxithromycin on the production of lipase and neutrophil chemotactic factor by Propionibacterium acnes.
    Akamatsu H; Tomita T; Horio T
    Dermatology; 2002; 204(4):277-80. PubMed ID: 12077521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility of Cutibacterium acnes to topical minocycline foam.
    Sutcliffe J; McLaughlin R; Webster G; Read AF; Drlica K; Elliott R; Stuart I
    Anaerobe; 2020 Apr; 62():102169. PubMed ID: 32058277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of oral antibiotics on acne vulgaris and their effects on quality of life: a multicenter randomized controlled trial using minocycline, roxithromycin and faropenem.
    Hayashi N; Kawashima M
    J Dermatol; 2011 Feb; 38(2):111-9. PubMed ID: 21269305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistance of propionibacteria to antibiotics used in the treatment of acne.
    Brown JM; Poston SM
    J Med Microbiol; 1983 Aug; 16(3):271-80. PubMed ID: 6224016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tetracycline and minocycline treatment.
    Leyden JJ; McGinley KJ; Kligman AM
    Arch Dermatol; 1982 Jan; 118(1):19-22. PubMed ID: 6460472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro antibiotic susceptibility patterns of Propionibacterium acnes isolated from acne patients: an Egyptian university hospital-based study.
    Abdel Fattah NS; Darwish YW
    J Eur Acad Dermatol Venereol; 2013 Dec; 27(12):1546-51. PubMed ID: 23279041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The resistance of Propionibacterium acnes and Staphylococcus epidermidis to cyclines. The Research and Study Group on Acne].
    Noyon V; Legallou F; Richet H; Dreno B
    Ann Dermatol Venereol; 1998 Dec; 125(12):885-7. PubMed ID: 9922860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treating Acne With Topical Antibiotics: Current Obstacles and the Introduction of Topical Minocycline as a New Treatment Option.
    Bonati LM; Dover JS
    J Drugs Dermatol; 2019 Mar; 18(3):240-244. PubMed ID: 30909327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Propionibacterium acnes resistance to antibiotics in acne patients.
    Leyden JJ; McGinley KJ; Cavalieri S; Webster GF; Mills OH; Kligman AM
    J Am Acad Dermatol; 1983 Jan; 8(1):41-5. PubMed ID: 6219134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The influence of coptidis rhizoma to lipase activity of Propionibacterium acnes].
    Higaki S; Hasegawa Y; Morohashi M; Sakamoto K; Yamagishi T
    Nihon Hifuka Gakkai Zasshi; 1990 Jul; 100(8):883-6. PubMed ID: 2232295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Propionibacterium acnes and antimicrobial resistance in acne.
    Dessinioti C; Katsambas A
    Clin Dermatol; 2017; 35(2):163-167. PubMed ID: 28274353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial susceptibility of strains of Propionibacterium acnes isolated from inflammatory acne.
    Gübelin W; Martínez MA; Molina MT; Zapata S; Valenzuela ME
    Rev Latinoam Microbiol; 2006; 48(1):14-6. PubMed ID: 17357569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In-vitro investigation of anti-acne properties of Mangifera indica L. kernel extract and its mechanism of action against Propionibacterium acnes.
    Poomanee W; Chaiyana W; Mueller M; Viernstein H; Khunkitti W; Leelapornpisid P
    Anaerobe; 2018 Aug; 52():64-74. PubMed ID: 29906773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.